Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Cardiac Science's advanced AED for professionals:

This article was originally published in Clinica

Executive Summary

The US FDA has given Cardiac Science clearance to market what the Irvine, California firm claims is a technologically advanced automated external defibrillator (AED) designed for use by medical and emergency rescue professionals. The Powerheart AED G3 PRO is unique in that it displays the victim's heart rhythm on a built-in high resolution colour electrocardiogram display and gives users the option of delivering defibrillation shocks either semi-automatically or manually during the emergency treatment of victims of sudden cardiac arrest. The device has a suggested list price of $3,995.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059369

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel